ClinicalTrials.gg
Biological

ETBX-051 clinical trials

Also written ETBX-051.

studies test it
16
open now
0
in phase 3
0
first study started
2017

How each study uses ETBX-051 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

ETBX-051
16

Studies by the year they started

16 studies that test it; most in 2018 (10)

Studies that test ETBX-051, by start year
YearStudies
20176
201810

By phase

A phase 1/2 study counts in both.

Phase 1
13
Phase 2
16

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 0

ImmunityBio, Inc. (16)

Often tested with

Tested in the same studies.

Nogapendekin alfa inbakicept (16) · ETBX-061 (16) · GI-6301 (16) · ETBX-011 (13) · GI-4000 (13) · Yeast-CEA vaccine (12) · ETBX-021 (8) · Albumin-Bound Paclitaxel (1)

Studies

Open first, then newest update. How each study uses ETBX-051 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Given beside what is tested · 3 — ETBX-051 is usual care or a partner of the new treatment

Codes

What other systems call ETBX-051 · ClinicalTrials.gg INT016126

  • UNII (FDA) BPG11IF0HWETBX-051One source FDA
  • NCI Thesaurus C143034Adenoviral Brachyury Vaccine ETBX-051One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.